Product Benefits

• Extended-release convenience: Provides steady prazosin release once daily—improves adherence and reduces blood pressure fluctuations.

• Treats multiple conditions: Indicator for hypertension, BPH-related urinary obstruction, Raynaud’s phenomenon, and congestive heart failure resistant to other therapies. 

• Lowers vascular resistance safely: Selectively blocks alpha‑1 receptors to relax vessels, lower diastolic BP, and enhance blood flow—without reflex tachycardia. 

Dosage & Administration

• May be taken with or without food; initial dose ideally 2–3 hours before sleep to minimize first-dose hypotension. 

Safety & Precautions

• Common side effects: Dizziness, dizziness when standing, headache, drowsiness, weakness, palpitations, syncope, blurred vision, insomnia, fatigue. 

• Drug interactions: Caution when co-administered with PDE‑5 inhibitors (e.g. sildenafil), beta-blockers, diuretics—risk of profound hypotension. Avoid alcohol.Contraindications & warnings:

• • Not recommended in patients with hypersensitivity to quinazolines.

  • Use cautiously in those with orthostatic hypotension, hepatic or renal impairment, or history of micturition syncope.

  • Pregnancy Category C; use only if benefits outweigh risks. Excreted in breast milk—avoid while breastfeeding unless advised. 

• Overdose management: Treat hypotension with fluid resuscitation and vasopressors if needed; symptomatic care; activated charcoal if early ingestion. 

Quick Facts Table

Summary

Prazopress‑ER 2.5 mg Tablet delivers long-acting blood pressure control and symptomatic relief for BPH and Raynaud's, with once-daily dosing and minimal rebound hypotension. The ER formulation improves tolerability and steady effect. Regular monitoring is advised, and use cautiously with other vasodilators or heart medications.